GlassScriptPrepare for your visit
James Y Lee
Family Medicine · Woodstock, GA · NPI 1790715621
One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.
What was reported
$11,273.47
in general payments reported to CMS, 2019-2025 · $1,361 in 2025
The $1,361 reported for 2025 was more than what 91% of Family Medicine providers received nationally (typical 2025 total: $153).
Who reported paying
General payments only, top 6 by amount.
- Novo Nordisk INC $2,069.04
- Astrazeneca Pharmaceuticals LP $1,369.93
- Sanofi-Aventis U.S. LLC $1,190.92
- Lilly USA, LLC $948.37
- Abbvie INC. $895.74
- Amgen INC. $434.48
Drugs and devices associated with these payments
Vraylar Ozempic Rybelsus Farxiga Mounjaro Trelegy Ellipta Kerendia Airsupra Arexvy Soliqua 100/33 Breztri Dexcom G6 Transmitter
Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.
Questions you might ask
- I saw James Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?
- Is there a generic or alternative to this medication, and would it work as well for me?
- What made you choose this particular treatment for my situation?
These are normal questions. A good clinician will welcome them.
Notes
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.
GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/80559/james-y-lee